Advertisement
Screener

MACROGENICS, INC. (MGNX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

MACROGENICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where MACROGENICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $81.04M went out.
  • Fiscal year ended 2025-12-31: from investing, $114.10M went out.
  • Fiscal year ended 2025-12-31: from financing, $69.51M came in.
  • Fiscal year ended 2025-12-31: change in cash, $125.62M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$81.04M-$114.10M-$288.00K$0.00$69.80M*-$125.62M
2024-12-31-$68.37M$149.30M-$2.48M$0.00$3.44M*$81.88M
2023-12-31-$78.20M-$80.08M-$306.00K$616.00K$150.05M*-$7.93M
2022-12-31-$86.96M$70.72M$0.00$1.08M$574.00K*-$14.59M
2021-12-31-$143.83M-$36.61M$117.82M$4.96M*-$57.66M
2020-12-31-$111.90M-$7.79M$170.46M$3.89M*$54.66M
2019-12-31-$134.27M-$79.36M$0.00$118.66M$1.31M*-$93.66M
2018-12-31-$153.23M$56.64M-$260.00K$103.26M$1.99M*$8.40M
2017-12-31$14.40M$77.88M-$40.00K$34.24M$1.14M*$127.63M
2016-12-31-$43.68M-$70.25M-$39.00K$0.00$1.89M*-$112.07M
2015-12-31-$13.66M-$152.11M-$29.00K$203.47M$911.00K*$38.58M
2014-12-31-$32.76M-$3.57M-$19.00K$76.72M$744.00K*$41.11M
2013-12-31-$14.17M-$2.96M$0.00$84.77M$1.10M*$68.74M
2012-12-31-$6.58M-$940.04K$46.83K-$7.47M
2011-12-31$6.76M-$500.21K$70.40K$12.01M*$18.34M

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$40.75M*$27.96M*$0.00*$56.00K*$60.12M*
2026-03-31-$35.81M$45.32M-$218.00K$11.00K$9.30M
2025-12-31$43.02M*-$65.99M*-$6.00K*$0.00*
2025-09-30-$30.19M*-$20.37M*$0.00*$0.00*
2025-06-30-$46.98M*-$37.64M*$0.00*$0.00*$69.74M*
2025-03-31-$46.89M$9.90M-$282.00K$0.00-$37.27M
2024-12-31-$38.41M*$41.47M*-$4.00K*$0.00*
2024-09-30$60.16M*$35.60M*-$74.00K*$5.00K*
2024-06-30-$44.48M*$47.44M*-$6.00K*$481.00K*
2024-03-31-$45.64M$24.79M-$2.39M$2.64M-$20.60M
2023-12-31-$28.04M*$38.82M*$0.00*$0.00*
2023-09-30-$35.25M*-$33.52M*-$141.00K*$0.00*$50.05M*
2023-06-30-$2.09M*-$113.48M*-$7.00K*$0.00*
2023-03-31-$12.83M$28.09M-$158.00K$616.00K$99.66M*$115.38M
2022-12-31$29.32M*-$5.79M*$14.00K*$1.08M*
2022-09-30-$9.42M*$71.95M*-$14.00K*$0.00*
2022-06-30-$49.16M*$23.04M*$0.00*$0.00*
2022-03-31-$57.70M-$18.48M$0.00$0.00-$76.14M
2021-12-31-$54.31M*-$13.55M*$0.00*$800.00K*
2021-09-30-$14.79M*-$2.62M*$19.62M*-$645.00K*
2021-06-30-$45.69M*$13.82M*$0.00*$2.35M*
2021-03-31-$29.04M-$34.26M$98.20M$2.46M*$37.37M
2020-12-31-$5.53M*-$16.07M*-$1.00K*-$38.00K*$1.14M*
2020-09-30-$25.68M*-$43.28M*$73.98M*
2020-06-30-$36.55M*$41.01M*$96.51M*$2.50M*
2020-03-31-$44.14M$10.56M$0.00-$33.42M
2019-12-31-$38.04M*$7.63M*$0.00*
2019-09-30-$17.39M*-$6.37M*$0.00*
2019-06-30-$48.84M*-$10.12M*$0.00*$633.00K*-$58.33M*
2019-03-31-$30.00M-$70.49M$118.66M$18.51M
2018-12-31-$27.23M*$45.07M*$0.00*$18.32M*
2018-09-30-$36.98M*-$6.00K*$0.00*-$36.85M*
2018-06-30-$57.73M*-$7.81M*$103.26M*$38.21M*
2018-03-31-$31.30M$19.39M$0.00$629.00K*-$11.28M
2017-12-31$111.84M*$8.64M*-$50.00K*$120.84M*
2017-09-30-$31.35M*$4.46M*$1.12M*-$25.74M*
2017-06-30-$30.75M*$73.13M*$192.00K*$33.54M*$76.11M*
2017-03-31-$35.33M-$8.36M$108.00K-$43.58M
2016-12-31-$28.33M*$2.03M*$0.00*-$25.80M*
2016-09-30$49.79M*-$3.16M*$0.00*$1.01M*$47.63M*
2016-06-30-$33.23M*-$56.59M*$0.00*-$89.69M*
2016-03-31-$31.91M-$12.53M$224.00K-$44.22M
2015-12-31-$24.16M*-$145.69M*$0.00*-$169.59M*
2015-09-30-$7.63M*-$2.61M*$140.78M*$130.74M*
2015-06-30-$25.46M*-$2.81M*$0.00*-$28.11M*
2015-03-31$43.59M-$997.00K$62.69M$105.54M
2014-12-31-$20.16M*-$1.66M*-$17.00K*-$21.60M*
2014-09-30-$14.33M*-$672.00K*$0.00*-$14.82M*
2014-06-30-$4.15M*-$795.00K*$0.00*-$4.71M*
2014-03-31$5.89M-$447.00K$76.73M$82.24M
2013-12-31-$1.18M*-$924.08K*$83.92M*$1.10M*$82.91M*
2013-09-30$807.00K*-$1.16M*$142.18K*-$212.00K*
2013-06-30-$9.95M*-$450.91K*$652.47K*-$9.74M*
2013-03-31-$3.85M-$425.09K$56.53K-$4.22M
2012-12-31$17.70M*-$409.91K*$2.52K*$17.29M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35